APALUTAMIDE FOR METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER IN TITAN: PROGNOSTIC IMPORTANCE OF PROSTATE-SPECIFIC ANTIGEN RESPONSES

被引：0
|
作者：
Chowdhury, Simon
Bjartell, Anders
Agarwal, Neeraj
Chung, Byung Ha
Given, Robert W.
Pereira de Santana Gomes, Andrea J.
Merseburger, Axel S.
Ozguroglu, Mustafa
Juarez Soto, Alvaro
Uemura, Hirotsugu
Ye, Dingwei
Lopez-Gitlitz, Angela
Londhe, Anil
Mundle, Suneel
Larsen, Julie S.
McCarthy, Sharon
Chi, Kim N.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD10-11
引用
收藏
页码：E250 / E250
页数：1
相关论文
共 50 条
  • [31] Treatment Options in Metastatic Castration-Sensitive Prostate Cancer
    Choudhury, Atish D.
    ONCOLOGY-NEW YORK, 2022, 36 (03): : 184 - 185
  • [32] Charting a course in metastatic castration-sensitive prostate cancer
    Madan, Ravi A.
    Dahut, William L.
    NATURE REVIEWS UROLOGY, 2015, 12 (07) : 368 - 369
  • [33] Prostate-specific antigen (PSA) response in Black patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) versus abiraterone acetate (ABI): A real-world comparison.
    Brown, Gordon Andrew
    Du, Shawn
    Khilfeh, Ibrahim
    Rossi, Carmine
    Burbage, Sabree
    Kinkead, Frederic
    Diaz, Lilian
    Pilon, Dominic
    Lowentritt, Benjamin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [34] Real-world (RW) comparison of prostate-specific antigen (PSA) response in patients with de novo metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) versus enzalutamide (ENZ)
    Lowentritt, Benjamin H.
    Khilfeh, Ibrahim
    Pilon, Dominic
    Du, Shawn
    Rossi, Carmine
    Kinkead, Frederic
    Diaz, Lilian
    Ellis, Lorie
    Lefebvre, Patrick
    Brown, Gordon Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] The prognostic value of pain in castration-sensitive prostate cancer
    Roberto Iacovelli
    Chiara Ciccarese
    Orazio Caffo
    Ugo De Giorgi
    Marcello Tucci
    Claudia Mosillo
    Davide Bimbatti
    Francesco Pierantoni
    Francesca Maines
    Chiara Casadei
    Consuelo Buttigliero
    Michele Milella
    Giampaolo Tortora
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 654 - 660
  • [36] The prognostic value of pain in castration-sensitive prostate cancer
    Iacovelli, Roberto
    Ciccarese, Chiara
    Caffo, Orazio
    De Giorgi, Ugo
    Tucci, Marcello
    Mosillo, Claudia
    Bimbatti, Davide
    Pierantoni, Francesco
    Maines, Francesca
    Casadei, Chiara
    Buttigliero, Consuelo
    Milella, Michele
    Tortora, Giampaolo
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 654 - 660
  • [37] Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
    Tohi, Yoichiro
    Kato, Takuma
    Kobayashi, Keita
    Daizumoto, Kei
    Fukuhara, Hideo
    Ohira, Shin
    Katayama, Satoshi
    Shimizu, Ryutaro
    Takamoto, Atsushi
    Nishimura, Kenichi
    Ikeda, Kenichiro
    Nagami, Taichi
    Hayashida, Yushi
    Hirama, Hiromi
    Naito, Hirohito
    Tomida, Ryotaro
    Sasaki, Yutaro
    Yamamoto, Shinkuro
    Shimizu, Shinjiro
    Sugimoto, Mikio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (02) : 167 - 174
  • [38] A cost-utility analysis of apalutamide for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).
    Parmar, Ambika
    Timilshina, Narhari
    Emmenegger, Urban
    Alibhai, Shabbir M. H.
    Smoragiewicz, Martin
    Sander, Beate
    Chan, Kelvin K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis
    Santoni, Matteo
    Massari, Francesco
    Rizzo, Alessandro
    Mollica, Veronica
    Cimadamore, Alessia
    Montironi, Rodolfo
    Battelli, Nicola
    TUMORI JOURNAL, 2023, 109 (02): : 157 - 163
  • [40] THE EFFECT OF PRIOR DOCETAXEL TREATMENT IN PATIENTS WITH METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER RECEIVING APALUTAMIDE PLUS ANDROGEN DEPRIVATION THERAPY (TITAN STUDY)
    Batten, Julia
    Chi, Kim N.
    Given, Robert
    Karsh, Lawrence
    Bhaumik, Amitabha
    Agarwal, Neeraj
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
12345